Skip to main content

Table 2 Clinical characteristics of the study population

From: Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3

  Cohort_1 (n = 21) Cohort_2 (n = 23) Cohort_3 (n = 73)
Gender
 Male (%) 61.9 30.4 53.4
 Female(%) 38.1 69.6 46.6
Age (Range) 67 (52–79) 67 (47–84) 65 (40–82)
Stage
 I-II (%) / / 28.7
 III (%) 57.1 56.5 39.7
 IV(%) 42.9 43.5 31.6
Tumor site
 Head 43.3 26.1 64.7
 Body 29.0 47.8 19.1
 Tail 19.0 17.4 6.8
 Multi localized 8.7 8.7 9.4
  1. The total number of cases, the male/female percentage, the mean age (years) with minimum and maximum value (range), stage and tumor localization of the three cohorts of PDAC patients. In each cohort, PDAC patients were compared to a cohort of age- and gender-matched healthy donors